Mechanical and radiological assessment of the influence of rhTGFβ‐3 on bone regeneration in a segmental defect in the ovine tibia: Pilot study

Limitations in the use of autologous bone graft, which is the gold standard therapy in bone defect healing, drive the search for alternative treatments. In this study the influence of rhTGFβ‐3 on mechanical and radiological parameters of a healing bone defect in the sheep tibia was assessed. In the sheep, an 18‐mm long osteoperiosteal defect in the tibia was treated by rhTGFβ‐3 seeded on a poly(L/DL‐lactide) carrier (n = 4). In a second group (n = 4), the defect was treated by the carrier only, in a third group (n = 4) by autologous cancellous bone graft, and in a fourth group (n = 2) the defect remained blank. The healing process of the defect was assessed by weekly in vivo stiffness measurements and radiology as well as by quantitative computed tomographic assessment of bone mineral density (BMD) every 4 weeks. The duration of the experiment was 12 weeks under loading conditions. In the bone graft group, a marginally significant higher increase in stiffness was observed than in the PLA/rhTGFβ‐3 group (p = 0.06) and a significantly higher increase than in the PLA‐only group (p = 0.03). The radiographic as well as the computed tomographic evaluation yielded significant differences between the groups (p = 0.03), indicating the bone graft treatment (bone/per area, 83%; BMD, 0.57 g/cm3) performing better than the PLA/rhTGFβ‐3 (38%; 0.23 g/cm3) and the PLA‐only treatment (2.5%; 0.09 g/cm3), respectively. Regarding the mechanical and radiological parameters assessed in this study, we conclude that rhTGFβ‐3 has a promoting effect on bone regeneration. However, under the conditions of this study, this effect does not reach the potential of autologous cancellous bone graft transplantation. © 2006 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 24:1670–1678, 2006

[1]  E. Schneider,et al.  Biomechanical evaluation of healing in a non‐critical defect in a large animal model of osteoporosis , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[2]  Peter Patka,et al.  Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein‐I or autologous bone marrow , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[3]  T. Turner,et al.  Aging Does Not Lessen the Effectiveness of TGFβ2‐Enhanced Bone Regeneration , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  Koichiro Takahashi,et al.  Bone regeneration by recombinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model. , 2003, Biomaterials.

[5]  S. Boden,et al.  Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in Humans: A Prospective, Randomized Clinical Pilot Trial 2002 Volvo Award in Clinical Studies , 2002, Spine.

[6]  J. Wozney,et al.  Clinical evaluation of recombinant human bone morphogenetic protein-2. , 2002, Clinical orthopaedics and related research.

[7]  T. Steffen,et al.  Porous tricalcium phosphate and transforming growth factor used for anterior spine surgery , 2001, European Spine Journal.

[8]  L. Deguzman,et al.  Combination of bone marrow and TGF-beta1 augment the healing of critical-sized bone defects. , 1998, Journal of pharmaceutical sciences.

[9]  R J O'Keefe,et al.  The potential role of transforming growth factor beta in fracture healing. , 1998, Clinical orthopaedics and related research.

[10]  J. Schmitt,et al.  Assessment of an experimental bone wax polymer plus TGF-beta 1 implanted into calvarial defects. , 1998, Journal of biomedical materials research.

[11]  L. Claes,et al.  Magnitudes of local stress and strain along bony surfaces predict the course and type of fracture healing. , 1998, Journal of biomechanics.

[12]  T. Gerhart,et al.  Healing Bone Using Recombinant Human Bone Morphogenetic Protein 2 and Copolymer , 1998, Clinical orthopaedics and related research.

[13]  M. Whitman Signal transduction: Feedback from inhibitory SMADs , 1997, Nature.

[14]  C. Bünger,et al.  Transforming growth factor-beta stimulates bone ongrowth. Hydroxyapatite-coated implants studied in dogs. , 1996, Acta orthopaedica Scandinavica.

[15]  A. Tencer,et al.  TGF-beta 1 forms functionally normal bone in a segmental sheep tibial diaphyseal defect. , 1996, The Journal of otolaryngology.

[16]  M. Grütter,et al.  The crystal structure of TGF‐β3 and comparison to TGF‐β2: Implications for receptor binding , 1996, Protein science : a publication of the Protein Society.

[17]  Y. Lu,et al.  Induction of osteogenesis by bovine platelet transforming growth factor-beta (TGF-beta) in adult mouse femur. , 1995, Chinese medical journal.

[18]  S. Perren,et al.  Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). , 1993, Journal of biomedical materials research.

[19]  J. Massagué,et al.  Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. , 1990, The Journal of biological chemistry.

[20]  M E Bolander,et al.  Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur , 1990, The Journal of cell biology.

[21]  R E Booth,et al.  Harvesting Autogenous Iliac Bone Grafts: A Review of Complications and Techniques , 1989, Spine.

[22]  B. Summers,et al.  Donor site pain from the ilium. A complication of lumbar spine fusion. , 1989, The Journal of bone and joint surgery. British volume.

[23]  M. Sporn,et al.  Peptide growth factors are multifunctional , 1988, Nature.

[24]  E. Canalis,et al.  Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. , 1987, The Journal of biological chemistry.

[25]  M. Sporn,et al.  Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. , 1983, The Journal of biological chemistry.

[26]  I. R. Toranto,et al.  Bone growth into porous carbon, polyethylene, and polypropylene prostheses. , 1975, Journal of biomedical materials research.

[27]  D. Kingsley,et al.  The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. , 1994, Genes & development.

[28]  J. Ranchalis,et al.  Controlled release of TGF-β1 from a biodegradable matrix for bone regeneration , 1994 .

[29]  M. Sporn,et al.  The Transforming Growth Factor-βs , 1991 .

[30]  M. Urist Introduction to Update on Osteochondral Allograft Surgery , 1989 .

[31]  E. Canalis,et al.  Effects of transforming growth factors on bone cells. , 1989, Connective tissue research.

[32]  H. Burchardt Biology of Cortical Bone Graft Incorporation , 1989 .

[33]  M. Sporn,et al.  Type beta transforming growth factor: a bifunctional regulator of cellular growth. , 1985, Proceedings of the National Academy of Sciences of the United States of America.